Paul A Gerlach, MD | |
2985 Cortez Ave, Idaho Falls, ID 83404-7554 | |
(208) 523-3373 | |
(208) 523-8746 |
Full Name | Paul A Gerlach |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 43 Years |
Location | 2985 Cortez Ave, Idaho Falls, Idaho |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215025648 | NPI | - | NPPES |
1215025648 | Other | NPI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | MD14220 (Tennessee) | Primary |
207RC0200X | Internal Medicine - Critical Care Medicine | MD14220 (Tennessee) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Idaho Falls Community Hospital, Llc | Idaho falls, ID | Hospital |
Mountain View Hospital | Idaho falls, ID | Hospital |
Eastern Idaho Regional Medical Center | Idaho falls, ID | Hospital |
Madison Memorial Hospital | Rexburg, ID | Hospital |
Bingham Memorial Hospital | Blackfoot, ID | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Idaho Heart Institute Pc | 8123081239 | 15 |
Mountain View Hospital Llc | 4486562774 | 176 |
News Archive
On Star Trek, it is easy to take for granted the incredible ability of futuristic doctors to wave small devices over the heads of both humans and aliens, diagnose their problems through evaluating changes in brain activity or chemistry, and then treat behavior problems by selectively stimulating relevant brain circuits.
Abbott today announced the formation of the Abbott Pandemic Defence Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats.
Roche Molecular Systems, Inc. announced today that preliminary data from its ATHENA (Addressing THE Need for Advanced HPV Diagnostics) trial support the importance of screening for human papillomavirus (HPV) genotypes that put women at highest risk for developing cervical cancer. ATHENA is a prospective, double-blind, multi-centered, 47,000-patient, U.S.-registration trial designed to demonstrate the effectiveness of HPV detection as part of a cervical cancer screening program.
Millennium: The Takeda Oncology Company today announced that Science magazine has named it among the best biopharmaceutical companies in the world for the fourth consecutive year. Each year Science conducts a survey to determine the top employers in the biotechnology, biopharmaceutical, pharmaceutical and related industries worldwide.
› Verified 9 days ago
Entity Name | Mountain View Hospital Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669462362 PECOS PAC ID: 4486562774 Enrollment ID: O20040527001343 |
News Archive
On Star Trek, it is easy to take for granted the incredible ability of futuristic doctors to wave small devices over the heads of both humans and aliens, diagnose their problems through evaluating changes in brain activity or chemistry, and then treat behavior problems by selectively stimulating relevant brain circuits.
Abbott today announced the formation of the Abbott Pandemic Defence Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats.
Roche Molecular Systems, Inc. announced today that preliminary data from its ATHENA (Addressing THE Need for Advanced HPV Diagnostics) trial support the importance of screening for human papillomavirus (HPV) genotypes that put women at highest risk for developing cervical cancer. ATHENA is a prospective, double-blind, multi-centered, 47,000-patient, U.S.-registration trial designed to demonstrate the effectiveness of HPV detection as part of a cervical cancer screening program.
Millennium: The Takeda Oncology Company today announced that Science magazine has named it among the best biopharmaceutical companies in the world for the fourth consecutive year. Each year Science conducts a survey to determine the top employers in the biotechnology, biopharmaceutical, pharmaceutical and related industries worldwide.
› Verified 9 days ago
Entity Name | Idaho Heart Institute Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477656718 PECOS PAC ID: 8123081239 Enrollment ID: O20041110000072 |
News Archive
On Star Trek, it is easy to take for granted the incredible ability of futuristic doctors to wave small devices over the heads of both humans and aliens, diagnose their problems through evaluating changes in brain activity or chemistry, and then treat behavior problems by selectively stimulating relevant brain circuits.
Abbott today announced the formation of the Abbott Pandemic Defence Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats.
Roche Molecular Systems, Inc. announced today that preliminary data from its ATHENA (Addressing THE Need for Advanced HPV Diagnostics) trial support the importance of screening for human papillomavirus (HPV) genotypes that put women at highest risk for developing cervical cancer. ATHENA is a prospective, double-blind, multi-centered, 47,000-patient, U.S.-registration trial designed to demonstrate the effectiveness of HPV detection as part of a cervical cancer screening program.
Millennium: The Takeda Oncology Company today announced that Science magazine has named it among the best biopharmaceutical companies in the world for the fourth consecutive year. Each year Science conducts a survey to determine the top employers in the biotechnology, biopharmaceutical, pharmaceutical and related industries worldwide.
› Verified 9 days ago
Entity Name | St Marks Professional Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912925629 PECOS PAC ID: 1355248089 Enrollment ID: O20100316001013 |
News Archive
On Star Trek, it is easy to take for granted the incredible ability of futuristic doctors to wave small devices over the heads of both humans and aliens, diagnose their problems through evaluating changes in brain activity or chemistry, and then treat behavior problems by selectively stimulating relevant brain circuits.
Abbott today announced the formation of the Abbott Pandemic Defence Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats.
Roche Molecular Systems, Inc. announced today that preliminary data from its ATHENA (Addressing THE Need for Advanced HPV Diagnostics) trial support the importance of screening for human papillomavirus (HPV) genotypes that put women at highest risk for developing cervical cancer. ATHENA is a prospective, double-blind, multi-centered, 47,000-patient, U.S.-registration trial designed to demonstrate the effectiveness of HPV detection as part of a cervical cancer screening program.
Millennium: The Takeda Oncology Company today announced that Science magazine has named it among the best biopharmaceutical companies in the world for the fourth consecutive year. Each year Science conducts a survey to determine the top employers in the biotechnology, biopharmaceutical, pharmaceutical and related industries worldwide.
› Verified 9 days ago
Entity Name | Mvh Bmc Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649699174 PECOS PAC ID: 2961791991 Enrollment ID: O20160608002399 |
News Archive
On Star Trek, it is easy to take for granted the incredible ability of futuristic doctors to wave small devices over the heads of both humans and aliens, diagnose their problems through evaluating changes in brain activity or chemistry, and then treat behavior problems by selectively stimulating relevant brain circuits.
Abbott today announced the formation of the Abbott Pandemic Defence Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats.
Roche Molecular Systems, Inc. announced today that preliminary data from its ATHENA (Addressing THE Need for Advanced HPV Diagnostics) trial support the importance of screening for human papillomavirus (HPV) genotypes that put women at highest risk for developing cervical cancer. ATHENA is a prospective, double-blind, multi-centered, 47,000-patient, U.S.-registration trial designed to demonstrate the effectiveness of HPV detection as part of a cervical cancer screening program.
Millennium: The Takeda Oncology Company today announced that Science magazine has named it among the best biopharmaceutical companies in the world for the fourth consecutive year. Each year Science conducts a survey to determine the top employers in the biotechnology, biopharmaceutical, pharmaceutical and related industries worldwide.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Paul A Gerlach, MD 2985 Cortez Ave, Idaho Falls, ID 83404-7554 Ph: (208) 523-3373 | Paul A Gerlach, MD 2985 Cortez Ave, Idaho Falls, ID 83404-7554 Ph: (208) 523-3373 |
News Archive
On Star Trek, it is easy to take for granted the incredible ability of futuristic doctors to wave small devices over the heads of both humans and aliens, diagnose their problems through evaluating changes in brain activity or chemistry, and then treat behavior problems by selectively stimulating relevant brain circuits.
Abbott today announced the formation of the Abbott Pandemic Defence Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats.
Roche Molecular Systems, Inc. announced today that preliminary data from its ATHENA (Addressing THE Need for Advanced HPV Diagnostics) trial support the importance of screening for human papillomavirus (HPV) genotypes that put women at highest risk for developing cervical cancer. ATHENA is a prospective, double-blind, multi-centered, 47,000-patient, U.S.-registration trial designed to demonstrate the effectiveness of HPV detection as part of a cervical cancer screening program.
Millennium: The Takeda Oncology Company today announced that Science magazine has named it among the best biopharmaceutical companies in the world for the fourth consecutive year. Each year Science conducts a survey to determine the top employers in the biotechnology, biopharmaceutical, pharmaceutical and related industries worldwide.
› Verified 9 days ago
Dr. Douglas N Whatmore, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3200 Channing Way, Ste 205, Idaho Falls, ID 83404 Phone: 208-535-4300 Fax: 208-535-4315 | |
Jordan Joseph Cormier, PA-C Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2330 Desoto St, Idaho Falls, ID 83404 Phone: 208-552-4909 Fax: 208-522-6101 | |
Dr. Shawn D Speirs, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3100 Channing Way, Idaho Falls, ID 83404 Phone: 208-227-2575 | |
Mr. Craig D Scoville, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2220 E 25th St, Idaho Falls, ID 83404 Phone: 208-542-9080 Fax: 208-542-9081 | |
Dr. Ned R Warner, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2770 Cortez Ave, Idaho Falls, ID 83404 Phone: 208-522-4000 Fax: 208-528-4254 | |
Luma Mohsin, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3100 Channing Way, Idaho Falls, ID 83404 Phone: 208-529-6111 |